🔎 Trials Near Me

Home › Idiopathic Hypersomnia › Ohio

Idiopathic Hypersomnia clinical trials in Ohio

7 studies for Idiopathic Hypersomnia are looking for participants at sites in Ohio.

Cities in Ohio

A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

  • Takeda Site 2, Cincinnati
  • Takeda Site 4, Cincinnati
RecruitingPhase 2/3
Ages 18 to 71 · All sexes · Updated Sep 18, 2026 · NCT07646678

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

  • Neuroscience Research Center, LLC, Canton
  • Intrepid Research, Cincinnati
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07500090

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

  • Intrepid Research, Cincinnati
  • Ohio Sleep Medicine and Neuroscience Institute, Dublin
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 19, 2026 · NCT07625280

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

  • Alkermes Investigational Site, Canton
  • Alkermes Investigational Site, Cincinnati
  • Alkermes Investigational Site, Cincinnati
  • and 1 more
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683

A Study of TAK-360 in Adults With Idiopathic Hypersomnia

  • Takeda Site 12, Cincinnati
  • Takeda Site 17, Cincinnati
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jul 15, 2026 · NCT06812078

A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

  • Cincinnati, Ohio, Cincinnati
  • Cleveland, OH, Cleveland
  • Dublin, Ohio, Dublin
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 27, 2026 · NCT06752668

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

  • Cincinnati, Ohio, Cincinnati
  • Dublin, Dublin
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.